Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+०.४७%
१,०६७.३६
+४.९६
+०.४७%
१,०६२.४०१,०६४.१४१,०७१.९९१,०६१.०२
SIXC
Communications
SIXC
Communications
SIXC
-०.५४%
६०३.४८
-३.२६
-०.५४%
६०६.७४६०६.७४६०९.८४६०२.३३
SIXE
Energy
SIXE
Energy
SIXE
+०.५४%
१,२४४.९३
+६.७२
+०.५४%
१,२३८.२११,२३६.६०१,२४७.७४१,२३२.१०
SIXI
Industrials
SIXI
Industrials
SIXI
+०.६८%
१,७३०.३८
+११.७७
+०.६८%
१,७१८.६११,७२३.२३१,७४१.४८१,७१७.४७
SIXM
Financials
SIXM
Financials
SIXM
+०.३३%
६३९.४७
+२.१०
+०.३३%
६३७.३७६३८.२७६४२.३०६३८.२७
SIXR
Staples
SIXR
Staples
SIXR
+०.१६%
८५४.९५
+१.३६
+०.१६%
८५३.५९८५४.०५८५८.१९८५१.३४
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+०.११%
२१८.५६
+०.२३
+०.११%
२१८.३३२१८.३३२१९.७३२१७.१५
SIXT
Technology
SIXT
Technology
SIXT
+१.०२%
३,६३१.५९
+३६.७८
+१.०२%
३,५९४.८१३,६२०.१०३,६५७.४७३,६१५.३४
SIXU
Utilities
SIXU
Utilities
SIXU
+०.८०%
९१५.७७
+७.२३
+०.८०%
९०८.५४९०९.५०९१७.३५९०७.०७
SIXV
Health care
SIXV
Health care
SIXV
+१.१९%
१,५१२.८१
+१७.८१
+१.१९%
१,४९५.००१,४९९.६११,५१७.१०१,४९९.६१
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.४१%
२,४०८.२१
+९.९०
+०.४१%
२,३९८.३१२,४०६.८२२,४२१.८०२,४०४.२२
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०२५
+४.१७%
(+०.००१०) 1D
मे २२, १६:१०:०६ GMT+१०  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BOT...
Open
A$ ०.०२
High
A$ ०.०३
Low
A$ ०.०२
Mkt. cap
८.१७ करोड
Avg. vol.
२.८४ करोड
Volume
३.८२ करोड
52-wk high
A$ ०.४०
52-wk low
A$ ०.०२
EPS
-A$ ०.०५
Shares outstanding
२.७२ अरब
No. of employees
११
News stories
From sources across the web
Yahoo Finance UK
Yahoo Finance UK
·
१ घण्टा पहिले
RBC Expects Any S&P 500 Correction to Stay Within 5%-10%
TipRanks
TipRanks
·
५७ मिनेट पहिले
Vanguard S&P 500 ETF Sees Strong Inflows Amid AI Rally
Investor's Business Daily
Investor's Business Daily
·
५१ मिनेट पहिले
Dow Jones Futures: Market Bets On Iran Deal; Tesla, These Five AI Plays Are At Buy Points
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees११
Founded१९८४
Headquarters-
Sector-
Last report
२०२६ जनवरी २७
Fiscal period
Q2 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
८२.५३ लाख / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
२७.०६ लाख
२७.०६ लाख
८२.५३ लाख
८२.५३ लाख
Cost of goods sold
१२.८१ लाख
१२.८१ लाख
२९.८० लाख
२९.८० लाख
Cost of revenue
१२.८१ लाख
१२.८१ लाख
२९.८० लाख
२९.८० लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.१४ करोड
२.१४ करोड
१.८३ करोड
१.८३ करोड
Operating expense
२.६९ करोड
२.६९ करोड
२.२१ करोड
२.२१ करोड
Total operating expenses
२.८२ करोड
२.८२ करोड
२.५१ करोड
२.५१ करोड
Operating income
-२.५५ करोड
-२.५५ करोड
-१.६८ करोड
-१.६८ करोड
Other non operating income
-
-
६.८३ लाख
६.८३ लाख
EBT including unusual items
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
EBT excluding unusual items
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.७८ करोड
-२.७८ करोड
-१.६६ करोड
-१.६६ करोड
Net profit margin
-१,०२५.७३%
-१,०२५.७३%
-२०१.११%
-२०१.११%
Earnings per share
-
-
-
-
Interest and investment income
३.४७ लाख
३.४७ लाख
३.५३ लाख
३.५३ लाख
Interest expense
-२६.६६ लाख
-२६.६६ लाख
-८.०२ लाख
-८.०२ लाख
Net interest expenses
-२३.१९ लाख
-२३.१९ लाख
-४.५० लाख
-४.५० लाख
Depreciation and amortization charges
५.७३ लाख
५.७३ लाख
५.९३ लाख
५.९३ लाख
EBITDA
-२.४९ करोड
-२.४९ करोड
-१.६२ करोड
-१.६२ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more